Latest News about psychedelics
Recent news which mentions psychedelics
COMPASS Pathways: Institutional Pressure Amid $43M Market Cap Decline, What's Next For This Psychedelics Co?
November 25, 2024
From Benzinga
Instagram Suspends Pro-Cannabis Veterans Group Without Explanation, Raising Censorship Concerns
November 25, 2024
From Benzinga
Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results
November 25, 2024
From Benzinga
How To Navigate Difficult Psychedelic Journeys: Research Insights
November 22, 2024
Tickers
NEWS
From Benzinga
From Benzinga
Denmark Moves Toward Permanent Medical Cannabis Program
November 21, 2024
Tickers
NEWS
From Benzinga
Study Reveals Psychedelic Ritual Cocktail In Ancient Egyptian Mug
November 21, 2024
Tickers
NEWS
From Benzinga
Georgia Lawmakers Take First Steps Toward Psychedelic-Assisted Therapy For Veterans
November 21, 2024
From Benzinga
Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards
November 20, 2024
From Benzinga
DEA's Case For Scheduling Psychedelics Challenged In Landmark Hearing
November 20, 2024
Tickers
NEWS
From Benzinga
Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
November 19, 2024
From Benzinga
From Benzinga
From Benzinga
Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders
November 18, 2024
From Benzinga
Medical Cannabis And Legal Cocaine: The Unusual Permit That Puts Border Laws In Check
November 16, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.